Determinants of medication compliance in schizophrenia: empirical and clinical findings.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Schizophrenia bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/SCHBUL/23.4.637PMID 9366000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Journal of Technology Assessment in Health Care (review)

  2015cited by this paper
• Informing patients about tardive dyskinesia

  1998cited by this paper
• A Controlled Study of Education About Drug Treatment in Schizophrenia

  1996cited by this paper
• Akathisia and Restless Legs

  1996cited by this paper
• Relationship Between Insight, Educational Background and Cognition in Schizophrenia

  1996cited by this paper
• Awareness of Illness in Schizophrenia and Outpatient Treatment Adherence

  1996cited by this paper
• Medication noncompliance and substance abuse among patients with schizophrenia.

  1996influential reference
• The content and context of compliance

  1995cited by this paper
• Conventional antipsychotic medications for schizophrenia.

  1995cited by this paper
• Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi.

  1995cited by this paper
• Promoting compliance: the patient-provider partnership.

  1995cited by this paper
• The capacity of a measure of disability (the LSP) to predict hospital readmission in those with schizophrenia

  1995influential reference
• Compliance with treatment in schizophrenia: a drug intervention program in a developing country

  1995influential reference
• Patient Decision Making: The Missing Ingredient in Compliance Research

  1995cited by this paper
• Treatment outcomes in schizophrenia: implications for practice, policy, and research.

  1995cited by this paper
• From compliance to collaboration in the treatment of schizophrenia

  1995cited by this paper
• Multiple-family groups and psychoeducation in the treatment of schizophrenia.

  1994influential reference
• Rating of medication influences (ROMI) scale in schizophrenia.

  1994cited by this paper
• Demographic factors associated with extreme non-compliance in schizophrenia

  1994cited by this paper
• Explaining Attitudes toward Medication Compliance among a Seriously Mentally 3Population

  1994cited by this paper
• Compliance with antipsychotic drug treatment: influence of side effects.

  1994cited by this paper
• Awareness of illness in schizophrenia and schizoaffective and mood disorders.

  1994cited by this paper
• MAINTENANCE ANTIPSYCHOTIC MEDICATION

  1993cited by this paper
• The clinical research base for the treatment of schizophrenia.

  1993cited by this paper
• Predicting Medication Compliance in a Psychotic Population

  1993cited by this paper
• Assessment of insight in psychosis.

  1993cited by this paper
• Medication compliance: a healthcare problem.

  1993cited by this paper
• What is wrong with compliance?

  1993cited by this paper
• Medication compliance: the patient's perspective.

  1993cited by this paper
• Medication compliance: the patient's perspective.

  1993cited by this paper
• Antipsychotic Drugs and their Side-Effects

  1993cited by this paper
• A two-year prospective study of treatment compliance in patients with schizophrenia

  1992influential reference
• Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.

  1992cited by this paper
• Patient compliance.

  1992cited by this paper
• Noncompliance in community psychiatry: a review of clinical interventions.

  1991cited by this paper
• Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia.

  1991influential reference
• Awareness of illness in schizophrenia.

  1991cited by this paper
• Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

  1990cited by this paper
• Medication Compliance and Health Education Among Outpatients With Chronic Mental Disorders

  1990cited by this paper
• The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome.

  1990cited by this paper
• The Effects of Monitoring and Feedback on Compliance

  1990cited by this paper
• Teaching Medication Management Skills to Schizophrenic Patients

  1990cited by this paper
• Medication compliance and substance abuse among schizophrenic patients.

  1990cited by this paper
• From noncompliance to collaboration in the treatment of schizophrenia.

  1990cited by this paper
• Tardive dyskinesia in psychiatric patients with substance use disorders.

  1990cited by this paper
• Compliance in Epilepsy

  1989cited by this paper
• Factors Associated with the Course and Outcome of Schizophrenia in India Results of a Two-Year Multicentre Follow-Up Study

  1989cited by this paper
• Alcohol Use and Abuse in Schizophrenia: A Prospective Community Study

  1989cited by this paper
• Insight in Schizophrenia. Its Relationship to Acute Psychopathology

  1989cited by this paper
• Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic

  1989influential reference
• Compliance in children and adults: review of studies.

  1988cited by this paper
• Compliance with chronic disease regimens: diabetes.

  1988cited by this paper
• Medical compliance as an ideology.

  1988cited by this paper
• Clinical symptomatology and drug compliance in schizophrenic patients

  1988influential reference
• Association between type of medication instruction and patients' knowledge, side effects, and compliance.

  1987cited by this paper
• Invitation to compliance. The Prolixin brunch.

  1987cited by this paper
• Promoting compliance with outpatient drug treatment.

  1987cited by this paper
• Some Psychodynamics of Non-Compliance

  1987cited by this paper
• Utility of the health belief model in examining medication compliance among psychiatric outpatients.

  1987influential reference
• Causes of Neuroleptic Noncompliance

  1986cited by this paper
• The adverse effects of intensive treatment of chronic schizophrenia.

  1986cited by this paper
• Noncompliance in schizophrenia.

  1986cited by this paper
• Noncompliance and Mental Health Systems

  1986cited by this paper
• Medication noncompliance in schizophrenia: codification and update.

  1986influential reference
• Prevention and Treatment of Neuroleptic Noncompliance

  1986cited by this paper
• Noncompliance in schizophrenia.

  1986cited by this paper
• Advances in Treating the Young Adult Chronic Patient: New Directions for Mental Health Services, No. 21, March 1984.

  1985cited by this paper
• Informing patients about tardive dyskinesia.

  1985influential reference
• Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report.

  1985cited by this paper
• One-year Outcome of Schizophrenic Patients - The Interaction of Chronicity and Neuroleptic Treatment*

  1985influential reference
• Response to antipsychotic medication: the doctor's and the consumer's view.

  1984cited by this paper
• Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.

  1984cited by this paper
• Advances in treating the young adult chronic patient

  1984cited by this paper
• Family Care of Schizophrenia: A Problem-solving Approach to the Treatment of Mental Illness

  1984cited by this paper
• Neuroleptic compliance in schizophrenic outpatients.

  1984cited by this paper
• Understanding and improving patient compliance.

  1984cited by this paper
• Differences in the Nature of Relapse and Subsequent Inpatient Course between Medication‐Compliant and Noncompliant Schizophrenic Patients

  1984influential reference
• Increasing medication compliance in young adult chronic psychiatric patients.

  1984cited by this paper
• Compliance with therapeutic regimens.

  1984cited by this paper
• Developing and maintaining adherence to long-term drug-taking regimens.

  1984cited by this paper
• Enhancing medication use in schizophrenic patients.

  1984cited by this paper
• Problems of compliance in the outpatient treatment of schizophrenia.

  1983cited by this paper
• Lithium test-dose methodology using flame photometry: problems and alternatives.

  1983cited by this paper
• Progress in Behavior Modification

  1983cited by this paper
• Problems of compliance in the outpatient treatment of schizophrenia.

  1983cited by this paper
• A comparison of patients who refuse and consent to neuroleptic treatment.

  1983influential reference
• A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

  1983influential reference
• Rehospitalized schizophrenics. What they report about illness, treatment and compliance.

  1983cited by this paper
• Relapse of psychiatric patients in foster care.

  1982influential reference
• Accuracy of patient interviews and estimates by clinical staff in determining medication compliance.

  1981cited by this paper
• Subjective response to antipsychotic drugs.

  1981cited by this paper
• Relapse in schizophrenia.

  1980cited by this paper
• Health psychology : a handbook : theories, applications, and challenges of a psychological approach to the health care system

  1979cited by this paper
• "Adherence" and the negotiated approach to patienthood.

  1979cited by this paper
• Medication compliance in outpatient psychiatry.

  1979influential reference
• Insight and adherence to medication in chronic schizophrenics.

  1979cited by this paper
• Compliance in Health Care

  1979cited by this paper
• Compliance with Therapeutic Regimens

  1978cited by this paper
• A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

  1978influential reference
• Schizophrenic and medical inpatients as informed drug consumers.

  1978influential reference

• Medication adherence, treatment satisfaction, and patient–doctor relationship in patients with mood disorders at a Saudi tertiary care hospital: a cross-sectional study

  2026cites this paper
• Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.

  2025cites this paper
• Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone users

  2025cites this paper
• Costly Consequences: Increasing Medication Adherence to Support Mental Health Stability

  2025cites this paper
• Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review

  2025cites this paper
• Factors contributing to treatment non-compliance in a large sample of psychiatric patients in Turkey.

  2025cites this paper
• Relapse and associated factors among psychiatric patients in Africa: a systematic review and meta-analysis

  2025cites this paper
• Working alliance, daily activities, and emotions in patients with schizophrenia spectrum disorders and treating staff: a study with the experience sampling method.

  2025cites this paper
• Hubungan Daya Tilik dan Self Stigma Terhadap Kepatuhan Minum Obat Pada Pasien Skizofrenia : A Cross-Sectional Study

  2025cites this paper
• Attitudes and ethical beliefs of Russian psychiatrists towards the use of coercive treatment practices.

  2025cites this paper
• The Pathology of Imagination: Picturing the Worst

  2024cites this paper
• Behavior Change Theories and Models Within Health Belief Model Research: A Five-Decade Holistic Bibliometric Analysis

  2024cites this paper
• Effects of Social Support on Medication Adherence Among Patients with Schizophrenia: Serial Multiple Mediation Model

  2024cites this paper
• Mobile Delivery Program to Prevent Relapse and Improve Functioning in Patients With Psychiatric Diseases

  2024cites this paper
• Vivir con psicofármacos: un estudio fotovoz comunitario en personas con alta adherencia al tratamiento en el sureste de España

  2024cites this paper
• Prevalence and associated factors of non-adherence to antihyperlipidemic medication: a nationwide cross sectional survey in Pakistan

  2024cites this paper
• Bei Risiken und Nebenwirkungen fragen Sie Ihre… Patientinnen und Patienten

  2023cites this paper
• Psychotropic Medication Adherence and Its Associated Factors Among Schizophrenia Patients: Exploring the Consistency of Adherence Scales

  2023cites this paper
• Working alliance in treating staff and patients with Schizophrenia Spectrum Disorder living in Residential Facilities.

  2023cites this paper
• Situation du parcours de réhabilitation concernant les patients hospitalisés au long cours. À partir d’une analyse clinique et catamnestique de 75 cas

  2023cites this paper
• Influencing factors of medication adherence in schizophrenic patients: a meta-analysis

  2023cites this paper
• The emperor has no clothes: A systematic view of the status and future of child custody evaluation (CCE)

  2023cites this paper
• Medication Self-Management in Hospitalised Patients with Schizophrenia or Bipolar Disorder: The Perceptions of Patients and Healthcare Providers

  2022cites this paper
• Neurophysiology in psychosis: The quest for disease biomarkers

  2022cites this paper
• Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis

  2022cites this paper
• The Moderating Effect of Demographics on Patient Adherence and Beliefs

  2022cites this paper
• A study of compliance and insight in patients with schizophrenia

  2022cites this paper
• The Effect of Objectively Collected Medication Adherence Information on Bipolar I and Major Depressive Disorder Treatment Decisions: A Randomized Case Vignette Study of Psychiatric Clinicians

  2022cites this paper
• Attitudes Toward Long-Acting Injectable Antipsychotics among Schizophrenia Patients in Southern Thailand: A Multihospital-Based Cross- Sectional Survey

  2022cites this paper
• Investigating differences of medications in hospitalized schizophrenia and schizoaffective disorder patients: impact of substance use

  2022cites this paper
• Psychiatrists’ Disclosure of the Side Effects of Medications to Patients with Schizophrenia in A Major Hospital in Nigeria

  2022cites this paper
• Evaluation of factors associated with medication adherence in patients with bipolar disorder using a medication event monitoring system: a 6‐month follow‐up prospective study

  2022cites this paper
• Non-adherence to medications among patients with mental disorders attending tertiary care in Oman

  2022cites this paper
• Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature

  2022cites this paper
• The Effect of Pharmacy-Led Medication Reconciliation on Odds of Psychiatric Relapse at a Community Hospital

  2022cites this paper
• Good Medication Adherence and its Association with Meaning in Life among Thai Individuals with Schizophrenia

  2022cites this paper
• Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians

  2022cites this paper
• Pakistan Neurological Pakistan of Neurological Sciences Sciences Factors affecting treatment compliance in psychiatric setting Factors affecting treatment compliance in psychiatric setting

  2021cites this paper
• Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation

  2021cites this paper
• Association of the First Antipsychotic Treatment Duration With the Re-Initiation of Treatment in Schizophrenia: A National Health Insurance Data-Based Study

  2021cites this paper
• The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia

  2021cites this paper
• Causes of Drugs Omission among Schizophrenic Patients in Baghdad City

  2021influential citation
• Interventions to Improve Medication Adherence in Patients with Schizophrenia or Bipolar Disorders: A Systematic Review and Meta-Analysis

  2021cites this paper
• The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders

  2021cites this paper
• Predictors of subjective well-being among individuals with severe psychiatric conditions.

  2021cites this paper
• Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.

  2021cites this paper
• A comparative study of long acting injectable antipsychotic agents and oral agents during covid-19 pandemic: Quality of life, adherence and shortage of supply

  2021cites this paper
• Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study.

  2021cites this paper
• Computational Mechanism for the Effect of Psychosis Community Treatment: A Conceptual Review From Neurobiology to Social Interaction

  2021cites this paper
• [Mental healthcare in Brazil: a multifaceted study in four large cities].

  2021cites this paper
• An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks

  2021cites this paper
• Predictors of therapeutic adherence in patients with severe mental illness

  2021cites this paper
• Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.

  2021cites this paper
• The perception of well-being: Do people with severe psychiatric conditions and their therapists put themselves in each other’s shoes?

  2021cites this paper
• Guidance on the clinical understanding and use of long‐acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements

  2021cites this paper
• Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems

  2020cites this paper
• Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder

  2020cites this paper
• Treatment Non-Compliance in Bipolar Affective Disorder Patients: A Study from a Tertiary Care Centre in Nepal

  2020cites this paper
• Socio-demographic and Clinical Factors Associated with Defaulting Outpatient Appointments in a Psychiatric Clinic, Malaysia

  2020cites this paper
• Targeting the problem of treatment non-adherence among mentally ill patients: The impact of loss, grief and stigma.

  2020cites this paper
• Primary caregivers experience of anti-psychotic medication: A qualitative study.

  2020cites this paper
• A qualitative study of medication adherence amongst people with schizophrenia.

  2020cites this paper
• Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia

  2020cites this paper
• The Effect of Objectively Collected Medication Adherence Information on Bipolar I and Major Depressive Disorder Treatment Decisions: A Randomized Case Vignette Study of Psychiatric Clinicians (Preprint)

  2020cites this paper
• Working with People with Mental Health Difficulties to Improve Adherence to Medication

  2020cites this paper
• Suizidalität bei schizophrenen Psychosen: eine aktuelle Übersicht

  2020cites this paper
• Mobile Texting and Lay Health Supporters to Improve Schizophrenia Care in a Resource-Poor Community in Rural China (LEAN Trial): Randomized Controlled Trial Extended Implementation

  2020cites this paper
• Psychosocial Care Service in the Mental Health Provision

  2020cites this paper
• Objectives of Recovery from Schizophrenia

  2020cites this paper
• The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia

  2019cites this paper
• A Meta-Analytic Review of Cognitive Functioning in Negative and Positive Symptoms of Schizophrenia

  2019influential citation
• International Journal of Medical and Biomedical Studies (IJMBS)

  2019cites this paper
• Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.

  2019cites this paper
• Level of Perceived Social Support and Associated Factors Among People With Schizophrenia Attending Out Patient Department At Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia 2017

  2019cites this paper
• Medication adherence in first‐episode psychosis patients in Singapore

  2019cites this paper
• Treatment Non-Compliance In Patients Suffering From Schizophrenia And Bipolar Affective Disorder (BPAD): A Comparative Study

  2019cites this paper
• Severity Of Relapse And Medication Adherence In Patient Of Schizophrenia: A Study From Nepal

  2019cites this paper
• Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms

  2019cites this paper
• Comparison of long-term efficacy and safety of blonanserin treatment in individuals with first-episode and relapsed schizophrenia: a 3-year retrospective study

  2019cites this paper
• Predicting medication noncompliance among patients with schizophrenia after hospital discharge

  2019cites this paper
• Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral hospital, north west Ethiopia, 2017

  2019cites this paper
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

  2019cites this paper
• The Impacts of Drug Price Regulations in China

  2019cites this paper
• Views and strategies of African-American caregivers of persons with schizophrenia on medication treatment and other supports

  2019cites this paper
• Moderating role of cannabis use between insight and depression in early psychosis.

  2019cites this paper
• Can Empathy Improve Therapeutic Adherence in Schizophrenia?

  2019cites this paper
• Group life shapes the psychology and biology of health: The case for a sociopsychobio model

  2019cites this paper
• Study of various factors affecting compliance in schizophrenia: A single center experience in India

  2019cites this paper
• Brain Stimulation and Behavioral Change

  2019cites this paper
• What can clinicians do to improve outcomes across psychiatric treatments: a conceptual review of non-specific components

  2019cites this paper
• Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment

  2019cites this paper
• Impact of hospital pharmacist-led home medication review program for people with schizophrenia: A prospective study from Malaysia

  2019influential citation
• EEG power spectrum analysis for schizophrenia during mental activity

  2019cites this paper
• Bluthochdrucktherapie 2018: Generika oder Originalsubstanzen – Quo vadis? // Modern Antihypertensive therapy: Generics or original substances. Quo vadis?

  2019cites this paper
• Prevalence of Non-Adherence to Treatment among Patients of Bipolar Affective Disorder

  2019cites this paper
• Preventing discrimination based on psychiatric risk biomarkers

  2019cites this paper
• Psikiyatri Polikliniği: Şizofreni Tedavisi Bağlamında Kesitsel Bir Çalışma

  2018cites this paper
• The Physical Health of Individuals Receiving Antipsychotic Medication: A Qualitative Inquiry on Experiences and Needs

  2018cites this paper
• Expanding Traditional Paradigms: An Integrative Approach to the Psychotherapeutic Treatment of Psychosis

  2018cites this paper
• Social Support and Its Relation with Medication Adherence among Patients with Psychiatric Illness

  2018cites this paper